Showing results (211-220 of 232) with videos related to
Sort By:
Pageof 24
Annals of Surgery|December 1, 1984
Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatmentM M Urist, C M Balch, S J Soong, et al.Cancer Treatment Reviews|June 1, 1989
Interleukin-2 alone and in combination with other cytokines in melanoma: the investigational approach at the University of Texas M.D. Anderson Cancer CenterD R Parkinson, M Talpaz, K H Lee, et al.American Journal of Surgery|October 17, 1998
Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissectionR J Bold, P F Mansfield, D H Berger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Sentinel lymph node biopsy for melanoma: controversy despite widespread agreementK M McMasters, D S Reintgen, M I Ross, et al.In Vivo (Athens, Greece)|November 1, 1991
Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapiesK Itoh, C M Balch, J L Murray, et al.Annals of Surgical Oncology|January 5, 2002
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsyS Dessureault, S J Soong, M I Ross, et al.Annals of Surgery|September 1, 1993
Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trialC M Balch, M M Urist, C P Karakousis, et al.Cancer|January 1, 1995
A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanomaM K Wallack, M Sivanandham, C M Balch, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1991
Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCCK Hayakawa, M A Salmeron, D R Parkinson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patientsJ E Gershenwald, W Thompson, P F Mansfield, et al.Pageof 24